Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-11
DOI
10.1007/s00415-021-10820-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis
- (2021) Richard K. Burt et al. BONE MARROW TRANSPLANTATION
- Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis
- (2020) Alice Mariottini et al. Multiple Sclerosis Journal
- Detection of disability worsening in relapsing‐remitting multiple sclerosis patients. A real‐world roving EDSS‐Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register
- (2020) Vito Lepore et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis
- (2019) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
- (2019) Basil Sharrack et al. BONE MARROW TRANSPLANTATION
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
- (2017) David Baker et al. JAMA Neurology
- Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study
- (2017) Ludwig Kappos et al. Multiple Sclerosis Journal
- Healthcare Outbreaks Associated With a Water Reservoir and Infection Prevention Strategies
- (2016) Hajime Kanamori et al. CLINICAL INFECTIOUS DISEASES
- Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial
- (2016) Harold L Atkins et al. LANCET
- Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis
- (2016) Hyunwoo Lee et al. Multiple Sclerosis Journal
- Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis
- (2016) Hyunwoo Lee et al. Multiple Sclerosis Journal
- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2015) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience
- (2014) Joachim Burman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation for multiple sclerosis – if confused or hesitant, remember: ‘Treat with standard immune suppressive drugs and if no inflammation, no response’
- (2012) Richard K Burt et al. Multiple Sclerosis Journal
- Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
- (2011) T. Daikeler et al. BLOOD
- Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience
- (2011) GL Mancardi et al. Multiple Sclerosis Journal
- Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
- (2009) Richard K Burt et al. LANCET NEUROLOGY
- High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation as a treatment option in multiple sclerosis
- (2008) Yury L. Shevchenko et al. EXPERIMENTAL HEMATOLOGY
- Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation
- (2008) J Fagius et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation